Profile for United States of America Patent: 9132239
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: 9132239
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Feb 1, 2032 | Novo | OZEMPIC | semaglutide |
⤷ Sign Up | Aug 1, 2032 | Novo | SAXENDA | liraglutide |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |